sparsentan will reduce the level or effect of modafinil by influencing hepatic enzyme CYP2C19 metabolism. Use Warning/Monitor. Sparsentan (a CYP2C19 inducer) decreases exposure of CYP2C19 substrates and minimizes efficacy relevant to these substrates. Abuse Likely: In clinical trials, modafinil use generates euphoric and psychoactive consequences, altering pondering, temper, thoughts, https://modafinil65421.newsbloger.com/26594310/everything-about-modafinil